Ionpath Receives Strategic Investment to Support Spatial Proteomics Innovation

MENLO PARK, Calif.--(BUSINESS WIRE)-- #oncology--Ionpath, a leader in high-definition spatial proteomics, announced that Thermo Fisher Scientific has made a strategic investment in the company.

Click to view original post